224 related articles for article (PubMed ID: 10091611)
21. Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies.
Kordower JH; Rosenstein JM; Collier TJ; Burke MA; Chen EY; Li JM; Martel L; Levey AE; Mufson EJ; Freeman TB; Olanow CW
J Comp Neurol; 1996 Jun; 370(2):203-30. PubMed ID: 8808731
[TBL] [Abstract][Full Text] [Related]
22. Alpha-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice.
Alerte TN; Akinfolarin AA; Friedrich EE; Mader SA; Hong CS; Perez RG
Neurosci Lett; 2008 Apr; 435(1):24-9. PubMed ID: 18314273
[TBL] [Abstract][Full Text] [Related]
23. Effects of orally administered levodopa on mesencephalic dopaminergic neurons undergoing a degenerative process.
Ferrario JE; Delfino MA; Stefano AV; Zbarsky V; Douhou A; Murer MG; Raisman-Vozari R; Gershanik OS
Neurosci Res; 2003 Dec; 47(4):431-6. PubMed ID: 14630347
[TBL] [Abstract][Full Text] [Related]
24. Low-Dose Aspirin Upregulates Tyrosine Hydroxylase and Increases Dopamine Production in Dopaminergic Neurons: Implications for Parkinson's Disease.
Rangasamy SB; Dasarathi S; Pahan P; Jana M; Pahan K
J Neuroimmune Pharmacol; 2019 Jun; 14(2):173-187. PubMed ID: 30187283
[TBL] [Abstract][Full Text] [Related]
25. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO
Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466
[TBL] [Abstract][Full Text] [Related]
26. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
27. Thrombin-induced microglial activation contributes to the degeneration of nigral dopaminergic neurons in vivo.
Huang CF; Li G; Ma R; Sun SG; Chen JG
Neurosci Bull; 2008 Apr; 24(2):66-72. PubMed ID: 18369384
[TBL] [Abstract][Full Text] [Related]
28. Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra.
Chu Y; Kompoliti K; Cochran EJ; Mufson EJ; Kordower JH
J Comp Neurol; 2002 Aug; 450(3):203-14. PubMed ID: 12209851
[TBL] [Abstract][Full Text] [Related]
29. Recruitment of calbindin into nigral dopamine neurons protects against MPTP-Induced parkinsonism.
Inoue KI; Miyachi S; Nishi K; Okado H; Nagai Y; Minamimoto T; Nambu A; Takada M
Mov Disord; 2019 Feb; 34(2):200-209. PubMed ID: 30161282
[TBL] [Abstract][Full Text] [Related]
30. Liposomal Form of L-Dopa and SH-Sy5y Cell-Derived Exosomes Modulate the Tyrosine Hydroxylase/Dopamine Receptor D2 Signaling Pathway in Parkinson's Rat Models.
Zarrin P; Dehghani Ashkezari M; Seifati SM
J Mol Neurosci; 2021 Dec; 71(12):2583-2592. PubMed ID: 34125397
[TBL] [Abstract][Full Text] [Related]
31. Does levodopa accelerate the pathologic process in Parkinson disease brain?
Parkkinen L; O'Sullivan SS; Kuoppamäki M; Collins C; Kallis C; Holton JL; Williams DR; Revesz T; Lees AJ
Neurology; 2011 Oct; 77(15):1420-6. PubMed ID: 21917769
[TBL] [Abstract][Full Text] [Related]
32. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
Hartmann A; Michel PP; Troadec JD; Mouatt-Prigent A; Faucheux BA; Ruberg M; Agid Y; Hirsch EC
J Neurochem; 2001 Mar; 76(6):1785-93. PubMed ID: 11259496
[TBL] [Abstract][Full Text] [Related]
33. The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease.
McNaught KS; Jnobaptiste R; Jackson T; Jengelley TA
Synapse; 2010 Mar; 64(3):241-50. PubMed ID: 19924695
[TBL] [Abstract][Full Text] [Related]
34. N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats.
Guan J; Krishnamurthi R; Waldvogel HJ; Faull RL; Clark R; Gluckman P
Brain Res; 2000 Mar; 859(2):286-92. PubMed ID: 10719076
[TBL] [Abstract][Full Text] [Related]
35. ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia.
Galter D; Buervenich S; Carmine A; Anvret M; Olson L
Neurobiol Dis; 2003 Dec; 14(3):637-47. PubMed ID: 14678778
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon.
Blanchard V; Raisman-Vozari R; Vyas S; Michel PP; Javoy-Agid F; Uhl G; Agid Y
Brain Res Mol Brain Res; 1994 Mar; 22(1-4):29-38. PubMed ID: 7912404
[TBL] [Abstract][Full Text] [Related]
37. l-3,4-dihydroxyphenylalanine (l-DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson's disease.
Billings JL; Gordon SL; Rawling T; Doble PA; Bush AI; Adlard PA; Finkelstein DI; Hare DJ
J Neurochem; 2019 Jul; 150(1):88-106. PubMed ID: 30716176
[TBL] [Abstract][Full Text] [Related]
38. Nigral depigmentation reflects monoamine exhaustion as initial step to Parkinson's disease.
Müller T; Kohlhepp W
Med Hypotheses; 2018 Jan; 110():46-49. PubMed ID: 29317067
[TBL] [Abstract][Full Text] [Related]
39. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
Oiwa Y; Yoshimura R; Nakai K; Itakura T
Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
[TBL] [Abstract][Full Text] [Related]
40. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.
Damier P; Hirsch EC; Agid Y; Graybiel AM
Brain; 1999 Aug; 122 ( Pt 8)():1421-36. PubMed ID: 10430829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
